Literature DB >> 7050735

Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.

M J Thoolen, P B Timmermans, P A van Zwieten.   

Abstract

In conscious unrestrained spontaneously hypertensive and normotensive rats, prepared with permanently indwelling abdominal aortic catheters, the effects of blood pressure and heart rate of a 12-day continuous subcutaneous infusion of guanfacine (10 mg/kg/day) and clonidine (500 micrograms/kg/day) and sudden interruption of these treatments were studied. Both drugs significantly and consistently reduced the mean arterial pressure and heart rate throughout the infusion period in the SH rats, but not in the normotensive animals. The magnitude of the effects of both drugs in the SH rat were similar. Following withdrawal of treatment with guanfacine, a discontinuation syndrome was evoked, much less severe than that observed after suspension of the infusion with clonidine. The withdrawal syndromes were characterized by an overshoot of heart rate and a period of blood pressure lability. In spite of the ineffectiveness of guanfacine and clonidine to reduce blood pressure and heart rate consistently in the normotensive rat, similar withdrawal patterns as those found in the SH rat were observed. These findings are in general agreement with the results previously found in clinical studies in hypertensive patients. The spontaneously hypertensive rat may prove a suitable animal model for pre-clinical studies of discontinuation symptoms after cessation of treatment with antihypertensive drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050735     DOI: 10.1007/bf00491483

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Technique for permanent long-term intubation of rat aorta.

Authors:  J W STILL; E R WHITCOMB
Journal:  J Lab Clin Med       Date:  1956-07

2.  Pharmacology of guanfacine.

Authors:  G Scholtysik
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

3.  Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues.

Authors:  A de Jonge; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

4.  Comparative haemodynamic effects of clonidine and guanfacine.

Authors:  H F Oates; L M Stoker; E P MacCarthy; J C Monaghan; G S Stokes
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-01

5.  Discontinuation syndrome after continuous infusion of clonidine in the spontaneously hypertensive rat.

Authors:  M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Life Sci       Date:  1981-05-11       Impact factor: 5.037

Review 6.  The clonidine withdrawal syndrome. Its reproduction and evaluation in laboratory animal models.

Authors:  M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Gen Pharmacol       Date:  1981

7.  Clonidine dependence in the guinea-pig isolated ileum.

Authors:  H O Collier; N J Cuthbert; D L Francis
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

8.  Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline.

Authors:  C Zamboulis; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

9.  Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.

Authors:  J L Reid; L M Wing; H J Dargie; C A Hamilton; D S Davies; C T Dollery
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

10.  Disposition of clonidine in rats as determined by radioimmunoassay.

Authors:  B Jarrott; S Spector
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

View more
  3 in total

1.  Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat.

Authors:  J Atkinson; N Boillat; T Dennis; S Z Langer; B Scatton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

Review 2.  Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

3.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.